| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/24/2011 | WO2010066437A3 Aqueous composition containing dexpanthenol and sodium chloride |
| 02/24/2011 | WO2010039997A3 Hematopoietic protection against chemotherapeutic compounds using selective cyclin-dependent kinase 4/6 inhibitors |
| 02/24/2011 | WO2010009120A8 Novel salts and polymorphs of desazadesferrithiocin polyether analogues as metal chelation agents |
| 02/24/2011 | WO2010003319A8 Hydrates of erythromycin salts, the preparation and the use thereof |
| 02/24/2011 | WO2009153434A8 Synthetic analogues of phosphatidyl-myo-inositol mannosides with an inhibitory activity on the inflammatory response |
| 02/24/2011 | WO2009149139A8 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 02/24/2011 | WO2009132265A3 Degradable compounds and methods of use thereof, particularly with particle replication in non-wetting templates |
| 02/24/2011 | WO2008130863A3 Substituted benzimidazoles |
| 02/24/2011 | US20110047631 Heat shock protein deficiencies as model systems for brain pathology and cancer |
| 02/24/2011 | US20110046982 Methods and compositions related to viral inhibition |
| 02/24/2011 | US20110046722 Oxazinyl isoflavonoid compounds, medicaments and use |
| 02/24/2011 | US20110046606 Catheter injectable depot compositions and uses thereof |
| 02/24/2011 | US20110046599 Multi-Day Delivery Of Biologically Active Substances |
| 02/24/2011 | US20110046579 Use of a 1-n-(halo-3-pyridylmethyl)-n-methylamino-1-alkylamino-2-nitroethylene derivative for preparing a topical veterinary pharmaceutical composition for combating external parasites |
| 02/24/2011 | US20110046532 composition including a silicone-based polymer and a method of treating skin disorders using the composition |
| 02/24/2011 | US20110046482 Methods for reducing toxicities associated with medical procedures employing radiographic contrast agents |
| 02/24/2011 | US20110046402 Novel method and intermediates for preparing 19-norsteroid compounds |
| 02/24/2011 | US20110046237 Compounds with activity at estrogen receptors |
| 02/24/2011 | US20110046236 Alcoholic compositions having a lowered risk of acetaldehydemia |
| 02/24/2011 | US20110046235 Products comprising, and uses of, decarboxylated phenolic acids derived from chlorogenic acids of coffee |
| 02/24/2011 | US20110046234 Retinaldehyde in the Treatment of Obesity, Diabetes and Other Conditions |
| 02/24/2011 | US20110046233 Gossypol derivatives, production method thereof and uses of same |
| 02/24/2011 | US20110046232 Orally Dissolving Formulations of Memantine |
| 02/24/2011 | US20110046231 Solid forms of (±)-o-desmethylvenlafaxine salts |
| 02/24/2011 | US20110046230 Salt of Dimethylaminomethyl-Phenyl-Cyclohexane and Crystalline Forms Thereof |
| 02/24/2011 | US20110046229 Controlled Release Drug Delivery Systems And Pharmaceutical Compositions Formed Therewith |
| 02/24/2011 | US20110046228 Methods for administration of colchicine with grapefruit juice |
| 02/24/2011 | US20110046227 treating familial Mediterranean fever or gout with combination of colchicine and atorvastatin |
| 02/24/2011 | US20110046226 Pharmaceutical compositions for prevention of overdose or abuse |
| 02/24/2011 | US20110046225 Pharmaceutical formulation containing palmitoyl ethanolamide and stearoyl ethanolamide |
| 02/24/2011 | US20110046224 Methods to accelerate muscle development, decrease fat deposits, and enhance feeding efficiency in pigs |
| 02/24/2011 | US20110046223 Treatment of neurofibromatosis |
| 02/24/2011 | US20110046222 Fatty acid amides and uses thereof |
| 02/24/2011 | US20110046221 Therapeutic intervention to mimic the effect of caloric restriction |
| 02/24/2011 | US20110046219 (het)aryl-p-quinone derivatives for treatment of mitochondrial diseases |
| 02/24/2011 | US20110046218 Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base |
| 02/24/2011 | US20110046217 Use of 2,2'-cyclolignans for inducing, restoring or stimulating the pigmentation of the skin, hair or hairs |
| 02/24/2011 | US20110046216 Stable compositions of dehydroascorbic acid |
| 02/24/2011 | US20110046215 Abnormal intraocular pressure treatment |
| 02/24/2011 | US20110046214 Composition inhibiting sex hormone-binding globulin |
| 02/24/2011 | US20110046213 Production of Delta 9 Tetrahydrocannabinol |
| 02/24/2011 | US20110046212 Use of oleuropein and derivatives in the treatment of type 2 diabetes mellitus and pathologies associated with protein aggregation phenomena |
| 02/24/2011 | US20110046211 Combination therapy of hedgehog inhibitors, radiation and chemotherapeutic agents |
| 02/24/2011 | US20110046210 Substituted thiopenecarboxamides as ikk-beta serine-, threonine-protein kinase inhibitors |
| 02/24/2011 | US20110046209 RNA-Induced Translational Silencing and Cellular Apoptosis |
| 02/24/2011 | US20110046208 Nucleolar targeting of therapeutics against hiv |
| 02/24/2011 | US20110046207 C5a binding nucleic acids |
| 02/24/2011 | US20110046206 Double strand compositions comprising differentially modified strands for use in gene modulation |
| 02/24/2011 | US20110046205 Method for dissolving charged nucleic acid in an organic liquid |
| 02/24/2011 | US20110046203 Antisense oligonucleotides for inducing exon skipping and methods of use thereof |
| 02/24/2011 | US20110046202 Method for testing a subject thought to have or to be predisposed to asthma |
| 02/24/2011 | US20110046201 Methods and compositions for seamless cloning of nucleic acid molecules |
| 02/24/2011 | US20110046200 Use of antisense oligonucleotides to effect translation modulation |
| 02/24/2011 | US20110046199 Small molecule inhibitors of hiv proteases |
| 02/24/2011 | US20110046198 Ketorolac tromethamine compositions for treating or preventing ocular pain |
| 02/24/2011 | US20110046197 3-aminocarbazole compounds, pharmaceutical composition containing the same and method for the preparation thereof |
| 02/24/2011 | US20110046195 Non-Lactone Carbocyclic and Heterocyclic Antagonists and Agonists of Bacterial Quorum Sensing |
| 02/24/2011 | US20110046194 3-Triazolylphenyl-substituted sulphide derivatives as acaricides and insecticides |
| 02/24/2011 | US20110046193 Deferacirox dispersible tablets |
| 02/24/2011 | US20110046192 Therapeutic drug for hypertension or prehypertension |
| 02/24/2011 | US20110046191 Combination of a muscarinic receptor antagonist and a beta-2-adrenoceptor agonist |
| 02/24/2011 | US20110046190 Combinations comprising a selective cyclooxygenase-2 inhibitor |
| 02/24/2011 | US20110046189 Heteroaryl-substituted bicyclic smac mimetics and the uses thereof |
| 02/24/2011 | US20110046188 Compositions comprising novel ppar ligands and anti-hyperlipemic agents |
| 02/24/2011 | US20110046187 Assessing congestive heart risk in patients treated or potentially to be treated with a peroxisome-proliferator-activator-receptor-gamma agonist or a thiazolidinedione |
| 02/24/2011 | US20110046185 Arylchalcogenoarylalkyl-substituted imidazolidine-2,4-diones, process for preparation thereof, medicaments comprising these compounds and use thereof |
| 02/24/2011 | US20110046184 Solid state forms of racemic ilaprazole |
| 02/24/2011 | US20110046183 Crystal of benzimidazole compound |
| 02/24/2011 | US20110046182 Efficient aspirin prodrugs |
| 02/24/2011 | US20110046181 Short duration depot formulations |
| 02/24/2011 | US20110046180 N-aryl-n-piperidin-4-yl-propionamide derivatives and their use as opioid receptor ligands |
| 02/24/2011 | US20110046179 Novel piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 02/24/2011 | US20110046177 Therapeutic quinoline and naphthalene derivatives |
| 02/24/2011 | US20110046176 Furanopyridine cannabinoid compounds and related methods of use |
| 02/24/2011 | US20110046175 Benzofuran cannabinoid compounds and related methods of use |
| 02/24/2011 | US20110046174 Kappa-opiate agonists for the treatment of diarrhea-predominant irritable bowel syndrome |
| 02/24/2011 | US20110046173 Combination analgesic opioid pain therapy |
| 02/24/2011 | US20110046172 Medicinal Compositions |
| 02/24/2011 | US20110046171 Arylsulfonyl pyrazoline carboxamidine derivatives as 5-ht6 antagonists |
| 02/24/2011 | US20110046170 Novel pyrimidine-pyridine derivatives |
| 02/24/2011 | US20110046169 Fused heterocyclic derivatives and use thereof |
| 02/24/2011 | US20110046168 Methods of treating diseases using quinazoline derivatives and pharmaceutical compositions containing them |
| 02/24/2011 | US20110046167 Acyclic amine inhibitors of 5-methytioadenosine phosphorylase and nucleosidase |
| 02/24/2011 | US20110046166 Purine derivatives as a3 adenosine receptor-selective agonists |
| 02/24/2011 | US20110046165 Certain chemical entitles, compositions and methods |
| 02/24/2011 | US20110046164 Purine Derivatives for Treatment of Cystic Diseases |
| 02/24/2011 | US20110046163 Furanopyrimidine cannabinoid compounds and related methods of use |
| 02/24/2011 | US20110046162 Fused cyanopyridines and the use thereof |
| 02/24/2011 | US20110046161 Hcv ns3 protease inhibitors |
| 02/24/2011 | US20110046160 Novel Class of Spiro Piperidines for the Treatment of Neurodegenerative Diseases |
| 02/24/2011 | US20110046159 Arylpyrazinone derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes |
| 02/24/2011 | US20110046158 Capped pyrazinoylguanidine sodium channel blockers |
| 02/24/2011 | US20110046157 Substituted hydroxamic acids and uses thereof |
| 02/24/2011 | US20110046156 Treatment of hearing and balance impairments with redox-active therapeutics |
| 02/24/2011 | US20110046155 Hydrobenzamide derivatives as inhibitors of hsp90 |
| 02/24/2011 | US20110046154 Use of aminopeptidase inhibitors or azaindole compounds for preventing or treating cancerous metastases from epithelial origin |
| 02/24/2011 | US20110046153 Medicaments |
| 02/24/2011 | US20110046151 Piperazinyl derivatives useful as modulators of the neuropeptide y2 receptor |
| 02/24/2011 | US20110046150 Use of n--4-(3-pyridyl)-2-pyridine-amine for the treatment of pulmonary hypertension |
| 02/24/2011 | US20110046149 2-amino-3-sulphonyl-tetrahydro-pyrazolo[1,5-a]pyrido-pyrimidine antagonists of serotonin 5-ht6 receptors, methods for the production and use thereof |